Sorry, no content matched your criteria.
Featured Story
This Policy Will Beat Down U.S. Profits
The new rules from the U.S. Treasury and Congress on tax inversions will hurt U.S. corporate profits.
The Allergan/Pfizer deal makes these problems clear.
Here's what investors need to know about the new tax rules...
The new rules from the U.S. Treasury and Congress on tax inversions will hurt U.S. corporate profits.
The Allergan/Pfizer deal makes these problems clear.
Here's what investors need to know about the new tax rules...